Literature DB >> 10878416

Evidence for progesterone synthesis by human umbilical cord blood erythrocytes.

A Loganath1, K L Peh, P C Chew, Y C Wong, S C Ng.   

Abstract

In order to determine whether human umbilical cord blood erythrocytes are capable of progesterone biosynthesis, sonicated preparations of plasma-free erythrocytes at the range of total cell numbers between 18.4 x 10(9) and 62.9 x 10(9) cells obtained from umbilical cord arterial and venous blood collected from normal pregnant women (n = 6, age 28-39 years) following spontaneous vaginal delivery were incubated with [7n-(3)H]-pregnenolone as substrate. The leucocyte content of the incubates was negligible (<0. 005%). Controls (n = 4, age 29-36 years; 27.6 x 10(9) to 42.7 x 10(9) erythrocytes) obtained from cord blood of normal pregnant women were heat-denatured preparations of cells. Using the reverse-isotope dilution technique, [(3)H]-progesterone was isolated and characterized yielding an overall enzymic conversion which ranged between 0.27 and 0.46%. The results indicate for the first time that cord blood erythrocytes possess the 3beta-hydroxysteroid dehydrogenase-5,4-en isomerase activity and are a source of progesterone in human pregnancy. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10878416     DOI: 10.1159/000014240

Source DB:  PubMed          Journal:  Biol Neonate        ISSN: 0006-3126


  2 in total

1.  Progesterone promotes differentiation of human cord blood fetal T cells into T regulatory cells but suppresses their differentiation into Th17 cells.

Authors:  Jee H Lee; Benjamin Ulrich; Jungyoon Cho; Jeongho Park; Chang H Kim
Journal:  J Immunol       Date:  2011-07-18       Impact factor: 5.422

Review 2.  T helper cell immunity in pregnancy and influence on autoimmune disease progression.

Authors:  Jonathon J Graham; Maria Serena Longhi; Michael A Heneghan
Journal:  J Autoimmun       Date:  2021-05-18       Impact factor: 7.094

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.